Skip to main content

Advertisement

Table 1 Patient clinical pathological variables

From: Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases

Clinical pathological variables number
Age (years)  
 ≤50 69 (53.5 %)
 >50 60 (46.5 %)
Tumor size (cm)a  
 ≤2 31 (24.0 %)
 >2, ≤5 74 (57.4 %)
 >5 22 (17.1 %)
 Unavailable 2 (1.6 %)
Lymph node stage  
 negative 65 (50.4 %)
 positive 64 (49.6 %)
Grade  
 G1 24 (18.6 %)
 G2 30 (23.3 %)
 G3 75 (58.1 %)
Clinical stagea  
 I 19 (14.7 %)
 II 62 (48.1 %)
 III and IV 46 (35.7 %)
 Unavailable 2 (1.6 %)
Histological type  
 IDC 101 (78.3 %)
 ILC 18 (14.0 %)
 Others 10 (7.8 %)
Ki-67 LI  
 Low (≤14 %) 39 (30.2 %)
 High (>14 %) 90 (69.8 %)
Chemotherapy  
 AC 45 (34.9 %)
 AC-T 72 (55.8 %)
 Others 10 (7.8 %)
 None 2 (1.6 %)
Radiotherapy  
 No 67 (51.9 %)
 Yes 62 (48.1 %)
Cohort  
 FAHHMU 49 (38.0 %)
 DLH 45 (34.9 %)
 DOGH 35 (27.1 %)
  1. Abbreviations: LN, lymph node; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; Ki-67 LI, Ki-67 label index; AC, Adriamycin/Cyclophosphamide; AC-T, Adriamycin/Cyclophosphamide-Taxol; FAHHMU, The Fifth Affiliated Hospital of Harbin Medical University; DLG, Daqing Longnan Hospital; DOGH, Daqing Oilfield General Hospital
  2. Note: afor the variable, data for two cases are unavailable from medical records